Keensight Capital’s Acquisition of Inke

Martina Bellini Europe Legal Chronicle
Tagged:

Clifford Chance has advised Neuraxpharm on the deal.Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announced the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here